This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Optum, Mayo Clinic Partner To Launch Optum Labs: An Open, Collaborative Research And Innovation Facility Focused On Better Care For Patients

Stocks in this article: UNH

Making a difference in the lives of patients

With the combined insights of Optum, Mayo and other partners, Optum Labs will be able to support patient care improvements in many areas, such as:

  • finding optimal treatments for conditions in a given setting;
  • understanding variations in care; and
  • examining the effectiveness of patient care programs and approaches

Using the rich data and other resources of Optum Labs, scientists will address a broad range of opportunities to improve care for patients. Examples of the work of Optum Labs scientists include measuring the best treatments for the serious blood cancer chronic myelogenous leukemia (CML), developing applications that measure the relative cost effectiveness of medical devices, analyzing how to improve the diagnosis of Hepatitis C and increasing the understanding of health disparities among the elderly.

“By combining the Mayo Clinic's robust clinical insight with Optum’s extensive claims information, we will be able to better understand health care delivery over time, compare the effectiveness of care we provide today, and analyze the total cost of care for specific procedures or diseases,” said Veronique Roger, M.D., M.P.H., director of the Mayo Clinic Center for the Science of Health Care Delivery. “This will help provide better care to patients, and help the health care industry better define value through outcomes instead of volumes.”

“Bringing together in one location health information and insights from many contributors can provide a deeper understanding of important trends and patient care issues that no single organization could achieve on its own,” said Andy Slavitt, group executive vice president of Optum. “At Optum Labs, we have the opportunity to generate insights and develop practical innovations that care providers, life sciences companies and government agencies can begin using today to improve patient care.”

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,672.60 -141.38 -0.79%
S&P 500 2,051.82 -11.33 -0.55%
NASDAQ 4,757.8790 +7.4820 0.16%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs